Professional Development Coordinator for the Office of Advanced Practice
Recognition & Awards
Expert Council for Clinical Excellence and Leadership, University of Colorado School of Medicine
(2018)
Full-Time Allied Health Provider of the Year Award, University of Colorado Hospital Medical Staff
(2013)
Teaching
Adjunct
(2017)
College of Nursing,
Other
Publications
Griff M, Crawley S, Rowland A, Seggelke S, Hawkins RM, Grafals M, Low Wang CC. Diabetes management at the time of renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 1293-P. Category 19: Transplantation.
Seggelke SA, Griff M, Crawley S, Rowland A, Hawkins RM, Low Wang CC. Dysglycemia in
patients without diabetes after renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 928-P. Category 13-B Health Care Delivery—Quality Improvement.
Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clinical Diabetes. 2021.
Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec 1;20(12):1303-8. PubMed PMID: 25100383
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun;20(6):536-9. PubMed PMID: 24326004
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low CC, Draznin B. Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocr Pract. 2013 Dec 10;:1-12. [Epub ahead of print] PubMed PMID: 24326004
Seggelke S, Everhart B. Management of type 2 diabetes. Nurse Pract. 2013 Jun 10;38(6):13-6. PubMed PMID: 23695708
Doctorate of Nursing Practice, Focused Practice Designation
(2018)
Clinical Nurse Specialist, Certificate
(0001)
Conditions & Treatments
Endocrine System (Hormones)
Clinical Interests
Inpatient Diabetes Care
Care Philosophy
I believe that I am part of team with the patient to help them deal with their diabetes. All patients deserve a provider who will listen and not judge, who will assist in suggesting the best evidence based treatments options, and who treats every patient as a person first and foremost.
Personal Interests
Spending time with my family in the mountains
Volunteer Activities
DAWN Clinic
Public Speaking Yes
Diabetes
General Information
Graduate Schools:
CNS, University of Colorado College of Nursing
(2008)
DNP, University of Colorado College of Nursing
(2018)
Undergraduate Schools:
BSN, University of Colorado - Health Sciences Center (CO)
(1997)